Presidio Medical was founded in 2017 and is headquartered in South San Francisco, CA. The clinical-stage, privately held medical device company is developing a transformational neuromodulation platform to treat diseases of undesired neural activity with a first indication in the treatment of chronic pain.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/26/23 | $72,000,000 | Series C |
Action Potential Venture Capital Deerfield Management Company, L.P. INVUS Opportunities ShangBay Capital | undisclosed |
